Literature DB >> 32209066

Correction to: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous venovenous hemofiltration.

Rita Jacobs1, Patrick M Honore2, Marc Diltoer1, Herbert D Spapen1.   

Abstract

Following publication of the original article [1], we have been notified that the approved number by the Ethical Committee was given incorrectly. In the section "Methods" stated that: The Central Ethical Committee of the University Hospital approved the study protocol (B.U.N. 143201318818), this number is incorrect and should be expressed as follows: B.U.N. 143201318819."

Entities:  

Year:  2020        PMID: 32209066      PMCID: PMC7093943          DOI: 10.1186/s12882-020-01749-1

Source DB:  PubMed          Journal:  BMC Nephrol        ISSN: 1471-2369            Impact factor:   2.388


Correction to: BMC Nephrol https://doi.org/10.1186/s12882-016-0334-3 Following publication of the original article [1], we have been notified that the approved number by the Ethical Committee was given incorrectly. In the section “Methods” stated that: The Central Ethical Committee of the University Hospital approved the study protocol (B.U.N. 143201318818), this number is incorrect and should be expressed as follows: B.U.N. 143201318819.
  1 in total

1.  Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration.

Authors:  Rita Jacobs; Patrick M Honore; Marc Diltoer; Herbert D Spapen
Journal:  BMC Nephrol       Date:  2016-08-26       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.